|
Market Closed -
Singapore S.E.
03:47:55 2026-11-16 EST
|
5-day change | 1st Jan Change | ||
| 0.0820 SGD | -8.89% |
|
-8.89% | -78.42% |
| Market Cap | 13.47M 2.6M 2.02M 1.84M 1.7M 1.53M 2.89M 190M 2.99M 20.4M 8.08M 102M 7.58M 7.42M 322M | P/E 2024 |
11.1x | P/E 2025 | -15.3x |
|---|---|---|---|---|---|
| Enterprise Value | 24.85M 4.81M 3.73M 3.39M 3.13M 2.83M 5.33M 350M 5.52M 37.63M 14.91M 188M 13.99M 13.69M 595M | EV / Sales 2024 |
1.62x | EV / Sales 2025 | 1.76x |
| Free-Float |
21.36% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -8.89% | ||
| 1 week | -8.89% | ||
| Current month | -18.00% | ||
| 1 month | -13.68% | ||
| 3 months | -34.40% | ||
| 6 months | -77.22% | ||
| Current year | -78.42% |
| 1 week | 0.08 | 0.09 | |
| 1 month | 0.08 | 0.1 | |
| Current year | 0.08 | 0.42 | |
| 1 year | 0.08 | 0.42 | |
| 3 years | 0.06 | 0.7 | |
| 5 years | 0.06 | 0.7 | |
| 10 years | 0.06 | 0.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
Xue Dan Wu
CEO | Chief Executive Officer | 63 | 2017-12-30 |
Pei Chan Tang
SEC | Corporate Secretary | - | - |
Moi Heyang Lin
SEC | Corporate Secretary | 59 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Heng Ching Chew
CHM | Chairman | 75 | 2009-01-04 |
Xue Dan Wu
BRD | Director/Board Member | 63 | 2004-04-15 |
Yong Teng Seow
BRD | Director/Board Member | 51 | 2023-09-30 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -8.89% | -8.89% | -79.75% | -6.82% | 2.21M | ||
| -0.01% | +2.36% | +41.46% | +145.49% | 1,286B | ||
| -0.34% | +0.99% | +42.76% | +89.82% | 688B | ||
| +0.36% | +1.11% | +26.74% | +114.47% | 521B | ||
| +1.14% | +2.04% | +42.51% | +72.81% | 386B | ||
| -0.89% | -1.51% | +57.78% | +43.65% | 364B | ||
| +1.27% | +1.72% | +28.34% | +63.11% | 302B | ||
| +0.37% | -0.23% | +3.25% | +38.05% | 287B | ||
| +0.25% | +0.54% | +36.88% | +73.88% | 252B | ||
| +0.60% | +0.02% | +36.48% | +127.27% | 208B | ||
| Average | -0.70% | +1.87% | +23.64% | +76.17% | 429B | |
| Weighted average by Cap. | +0.12% | +3.26% | +37.38% | +99.59% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 67.65M 13.08M 10.15M 9.22M 8.52M 7.69M 14.52M 953M 15.03M 102M 40.59M 511M 38.08M 37.27M 1.62B | 43.75M 8.46M 6.56M 5.96M 5.51M 4.98M 9.39M 616M 9.72M 66.25M 26.25M 331M 24.63M 24.1M 1.05B |
| Net income | 8.28M 1.6M 1.24M 1.13M 1.04M 941K 1.78M 117M 1.84M 12.53M 4.97M 62.56M 4.66M 4.56M 198M | -4.3M -832K -645K -586K -542K -489K -923K -60.58M -956K -6.51M -2.58M -32.51M -2.42M -2.37M -103M |
| Net Debt | 11.66M 2.25M 1.75M 1.59M 1.47M 1.33M 2.5M 164M 2.59M 17.65M 6.99M 88.12M 6.56M 6.42M 279M | 11.38M 2.2M 1.71M 1.55M 1.43M 1.29M 2.44M 160M 2.53M 17.24M 6.83M 86.03M 6.41M 6.27M 273M |
Employees
1,096
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-11-16 | SGD 0.0820 | -8.89% | 34,200 |
- Stock Market
- Stocks
- BFK Stock
Select your edition
All financial news and data tailored to specific country editions
















